Page 27 - GTM-2-2
P. 27

Global Translational Medicine                                     Use of cardio biomarker in diagnosis of AMI



            Author contributions                                  injury by assessment of the plasma ratio of myoglobin over
                                                                  fatty acid-binding protein. Circulation, 92: 2848–2854.
            Conceptualization: Vishal Modi
            Writing – original draft: Rupali Shinde               https://doi.org/10.1161/01.cir.92.10.2848
            Writing – review & drafting: Isha Juwarwala, Vishal Modi,   9.   Lewandrowski K, Chen A, Januzzi J, 2002, Cardiac markers
               Chandni V. Chandarana                              for myocardial infarction. A brief review. Am J Clin Pathol,
                                                                  118: S93–S99.
            Ethics approval and consent to participate            https://doi.org/10.1309/3ek7-yvv9-228c-e1xt
            Not applicable.                                    10.  Tilea I, Varga A, Serban RC, 2021, Past, present, and future
                                                                  of blood biomarkers for the diagnosis of acute myocardial
            Consent for publication                               infarction-promises and challenges.  Diagnostics (Basel),
            Not applicable.                                       11: 881.
                                                                  https://doi.org/10.3390/diagnostics11050881
            Availability of data
                                                               11.  Reyes-Retana JA, Duque-Ossa LC, 2021, Acute myocardial
            Not applicable.                                       infarction biosensor: A review from bottom up. Curr Probl
                                                                  Cardiol, 46: 100739.
            References
                                                                  https://doi.org/10.1016/j.cpcardiol.2020.100739
            1.   Ojha N, Dhamoon AS, 2022, Myocardial infarction. In:   12.  High-sensitivity Troponin Test: Normal and High Levels.
               StatPearls. Treasure Island, FL: StatPearls Publishing.   Available  from:  https://www.medicinenet.com/high_
               Available  from:  https://www.ncbi.nlm.nih.gov/books/  sensitivity_troponin_test_ranges_and_values/article.htm
               nbk537076 [Last accessed on 2023 Jun 06].
                                                                  [Last accessed on 2023 Jun 06].
            2.   Savonnet M, Rolland T, Cubizolles M, et al., 2021, Recent   13.  Vasile VC, Jaffe AS, 2017, High-sensitivity cardiac troponin
               advances in cardiac biomarkers detection: From commercial
               devices to emerging technologies.  J  Pharm Biomed Anal,   for the diagnosis of patients with acute coronary syndromes.
               194: 113777.                                       Curr Cardiol Rep, 19: 92.
                                                                  https://doi.org/1010.1007/s11886-017-0904-4
               https://doi.org/10.1016/j.jpba.2020.113777
                                                               14.  Collinson PO, Boa FG, Gaze DC, 2001, Measurement of
            3.   Ahammad AJS, Choi YH, Koh K,  et al., 2011,
               Electrochemical detection of cardiac biomarker troponin I   cardiac troponins. Ann Clin Biochem, 38: 423–449.
               at gold nanoparticle-modified ITO electrode by using open      https://doi.org/10.1177/000456320103800501
               circuit potential. Int J Electrochem Sci, 6: 1906–1916.  15.  Shave R, Dawson E, Whyte G,  et al., 2002, The
            4.   Mahajan VS, Jarolim P, 2011, How to interpret elevated   cardiospecificity of the third-generation cTnT assay after
               cardiac troponin levels. Circulation, 124: 2350–2354.   exercise-induced muscle damage.  Med Sci Sports  Exerc,
                                                                  34: 651–654.
               https://doi.org/10.1161/circulationaha.111.023697
                                                                  https://doi.org/10.1097/00005768-200204000-00014
            5.   Rashid S, Malik A, Khurshid R, et al., 2019, The diagnostic
               value of biochemical cardiac markers in acute myocardial   16.  Chan D, Ng LL, 2010, Biomarkers in acute myocardial
               infarction. In: Myocardial Infarction. London, UK:   infarction. BMC Med, 8: 34.
               IntechOpen.
                                                                  https://doi.org/10.1186/1741-7015-8-34
               https://doi.org/10.5772/intechopen.76150
                                                               17.  Hazen SL, Heinecke JW, 1997, 3-chlorotyrosine, a specific
            6.   Falahati A, Sharkey SW, Christensen D,  et al., 1999,   marker of myeloperoxidase-catalyzed oxidation, is markedly
               Implementation of serum cardiac troponin I as marker   elevated in low density lipoprotein isolated from human
               for detection of acute myocardial infarction.  Am Heart J,   atherosclerotic intima. J Clin Invest, 99: 2075–2081.
               137: 332–337.
                                                                  https://doi.org/10.1172/JCI119379
               https://doi.org/10.1053/hj.1999.v137.92412
                                                               18.  Thukkani AK, McHowat J, Hsu FF, et al., 2003, Identification
            7.   Garg P, Morris P, Fazlanie AL,  et al., 2017, Cardiac   of alpha-chloro fatty aldehydes and unsaturated
               biomarkers of acute coronary syndrome: From history   lysophosphatidylcholine molecular species in human
               to high-sensitivity cardiac troponin.  Intern Emerg Med,   atherosclerotic lesions. Circulation, 108: 3128–3133.
               12: 147–155.
                                                                  https://doi.org/10.1161/01.cir.0000104564.01539.6a
               https://doi.org/10.1007/s11739-017-1612-1
                                                               19.  Beckmann JS, Ye YZ, Anderson PG, et al., 1994, Extensive
            8.   Van Nieuwenhoven FA, Kleine AH, Wodzig KH, et al., 1995,   nitration of protein tyrosines in human atherosclerosis
               Discrimination  between  myocardial  and  skeletal  muscle   detected by immunohistochemistry.  Biol Chem Hoppe


            Volume 2 Issue 2 (2023)                         9                        https://doi.org/10.36922/gtm.0403
   22   23   24   25   26   27   28   29   30   31   32